New results from a clinical trial conducted in Shanghai, China, indicate that adding cetuximab (Erbitux) to standard chemotherapy enables some patients with otherwise inoperable liver metastases due to colorectal cancer have their metastases surgically removed. Such surgery can be curative, and is generally critical to long-term survival. While this combination regimen is a standard treatment option for many patients with advanced colorectal cancer, this is the first randomized study to explore its impact on inoperable liver metastases...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/28tErJMLZJ0/258791.php
auto sport medical rehab
No comments:
Post a Comment